WO2003048360A1 - Nouvelles proteines se liant a une cible mammifere de la rapamycine (mtor) et genes de ces proteines - Google Patents

Nouvelles proteines se liant a une cible mammifere de la rapamycine (mtor) et genes de ces proteines Download PDF

Info

Publication number
WO2003048360A1
WO2003048360A1 PCT/JP2002/012835 JP0212835W WO03048360A1 WO 2003048360 A1 WO2003048360 A1 WO 2003048360A1 JP 0212835 W JP0212835 W JP 0212835W WO 03048360 A1 WO03048360 A1 WO 03048360A1
Authority
WO
WIPO (PCT)
Prior art keywords
mtor
rapamycin
acid sequence
amino acid
genes
Prior art date
Application number
PCT/JP2002/012835
Other languages
English (en)
French (fr)
Inventor
Kazuyoshi Yonezawa
Kenta Hara
Kenichi Yoshino
Chiharu Tokunaga
Original Assignee
The New Industry Research Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The New Industry Research Organization filed Critical The New Industry Research Organization
Priority to JP2003549537A priority Critical patent/JPWO2003048360A1/ja
Priority to AU2002354443A priority patent/AU2002354443A1/en
Publication of WO2003048360A1 publication Critical patent/WO2003048360A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
PCT/JP2002/012835 2001-12-07 2002-12-06 Nouvelles proteines se liant a une cible mammifere de la rapamycine (mtor) et genes de ces proteines WO2003048360A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2003549537A JPWO2003048360A1 (ja) 2001-12-07 2002-12-06 哺乳動物のラパマイシン標的タンパク質（ｍＴＯＲ）に結合する性質を持つ新規タンパク質およびその遺伝子
AU2002354443A AU2002354443A1 (en) 2001-12-07 2002-12-06 NOVEL PROTEINS BINDING TO MAMMALIAN TARGET OF RAPAMYCIN (mTOR) AND GENES THEREOF

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001375080 2001-12-07
JP2001-375080 2001-12-07

Publications (1)

Publication Number Publication Date
WO2003048360A1 true WO2003048360A1 (fr) 2003-06-12

Family

ID=19183512

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/012835 WO2003048360A1 (fr) 2001-12-07 2002-12-06 Nouvelles proteines se liant a une cible mammifere de la rapamycine (mtor) et genes de ces proteines

Country Status (3)

Country Link
JP (1) JPWO2003048360A1 (ja)
AU (1) AU2002354443A1 (ja)
WO (1) WO2003048360A1 (ja)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022660A2 (en) * 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022660A2 (en) * 2000-09-11 2002-03-21 Hyseq, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HARA K. ET AL.: "Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action", CELL, vol. 110, no. 2, 26 July 2002 (2002-07-26), pages 177 - 189, XP002966315 *
ISOTANI S. ET AL.: "Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro", J. BIOL. CHEM., vol. 274, no. 48, 26 November 1999 (1999-11-26), pages 34493 - 34498, XP002966314 *
KIM D.H. ET AL.: "mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery", CELL, vol. 110, no. 2, 26 July 2002 (2002-07-26), pages 163 - 175, XP002966316 *

Also Published As

Publication number Publication date
JPWO2003048360A1 (ja) 2005-04-14
AU2002354443A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
IN2014CN02050A (ja)
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2002044385A1 (fr) Gene codant une proteine de synthase d'acide acetolactique
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
WO2002061076A1 (en) Adiponectin-associated protein
WO2004035618A3 (en) Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
WO2003040370A1 (fr) Proteines du metabolisme permettant de lutter contre les mauvaises herbes, leurs genes et leur utilisation
EP1548107A4 (en) CHROMOPROTEIN AND FLUOROPROTEINS
WO2005079523A3 (en) Novel teleost derived antimicrobal polypeptides
AU2002307510A1 (en) Cytokine protein family
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
WO2002092758A8 (en) Gastrokines and derived peptides including inhibitors
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
IL142709A0 (en) Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
AU2001248822A1 (en) Gd3-mimetic peptides
WO2003048360A1 (fr) Nouvelles proteines se liant a une cible mammifere de la rapamycine (mtor) et genes de ces proteines
WO2000006706A3 (en) Map kinase phosphatase mutant
WO2002064782A3 (en) Rank ligand-binding polypeptides
EP1602721B8 (en) Koji mold-origin phospholipase a sb 2 /sb
WO2005086595A3 (ja) テロメアタンパク質ｔｒｆ２ｄｎａ結合ドメイン変異体タンパク質、テロメアｄｎａ変異体及びｔｒｆ２ｄｎａ結合ドメインと二重らせんｄｎａとの複合体構造の利用
EP1097999A3 (en) Abscisic acid responsive element-binding transcription factors
EP1568775A4 (en) CANCER ASSOCIATED GEN
WO2002008424A1 (fr) Genes abca2 humain et de rat
WO2003018806A1 (fr) Nouveau gene humain bmcc1
WO2003021263A1 (fr) Utilisation d'une proteine de recepteur couple a une proteine g

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003549537

Country of ref document: JP

122 Ep: pct application non-entry in european phase